Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies-Reference-Cited by-同舟云学术

Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies

Published:2024-04-10 Issue: Volume: Page:
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Mer Ali Hussein,Mirzaei Yousef,Misamogooe Fatemeh,Bagheri Nader,Bazyari Ahmadreza,Keshtkaran Zahra,Meyfour Anna,Shahedi Alireza,Amirkhani Zahra,Jafari Ameneh,Barpour Nesa,Jahandideh Saeed,Rezaei Behzad,Nikmanesh Yousef,Abdollahpour‐Alitappeh Meghdad^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13346-024-01564-3.pdf

Reference116 articles.

1. Kim KH, Kim H. Progress of antibody-based inhibitors of the HGF-cMET axis in cancer therapy. Exp Mol Med. 2017;49(3): e307.

2. Tempest PR, Stratton MR, Cooper CS. Structure of the met protein and variation of met protein kinase activity among human tumour cell lines. Br J Cancer. 1988;58(1):3–7.

3. Gherardi E, Birchmeier W, Birchmeier C, Vande WG. Targeting MET in cancer: rationale and progress. Nat Rev Cancer. 2012;12(2):89–103.

4. Mo HN, Liu P. Targeting MET in cancer therapy. Chronic Dis Transl Med. 2017;3(3):148–53.

5. Zhang Y, Xia M, Jin K, Wang S, Wei H, Fan C, et al. Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities. Mol Cancer. 2018;17(1):45.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and preclinical advances in PSMA-Directed Antibody-Drug conjugates (ADCs): Current status and hope for the future;Bioorganic Chemistry;2024-12

2. Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence;Life Sciences;2024-09

3. Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies;MedComm;2024-07-28

4. Antibody-Drug Conjugates: A promising breakthrough in cancer therapy;International Journal of Pharmaceutics;2024-06